12.44
0.20 (1.63%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bullish | Bearish |
Medical Devices (Global) | Bullish | Bearish | |
Stock | Alphatec Holdings, Inc. | Bullish | Bullish |
Analyst Consensus
3 Buy
Avg. Price @ Call: 13.69
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Core |
52 Weeks Range |
8.66 - 19.14
|
|
Price Target Range | ||
High | 25.00 (Canaccord Genuity, 100.96%) | Buy |
Median | 23.00 (84.89%) | |
Low | 20.00 (HC Wainwright & Co., 60.77%) | Buy |
Average | 22.67 (82.21%) | |
Total | 3 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Needham | 28 Mar 2024 | 23.00 (84.89%) | Buy | 13.79 |
20 Mar 2024 | 22.00 (76.85%) | Buy | 13.78 | |
Canaccord Genuity | 20 Mar 2024 | 25.00 (100.96%) | Buy | 13.78 |
HC Wainwright & Co. | 04 Mar 2024 | 20.00 (60.77%) | Buy | 13.49 |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
KONING JOHN TODD | - | 12.74 | -37,500 | -477,750 |
Aggregate Net Quantity | -37,500 | |||
Aggregate Net Value ($) | -477,750 | |||
Aggregate Avg. Buy ($) | - | |||
Aggregate Avg. Sell ($) | 12.74 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
KONING JOHN TODD | Officer | 24 Apr 2024 | Automatic sell (-) | 37,500 | 12.74 | 477,750 |
Date | Type | Details |
---|---|---|
02 May 2024 | Announcement | ATEC to Present at Upcoming Conferences |
17 Apr 2024 | Announcement | ATEC to Report First Quarter Financial Results on May 7, 2024 |
27 Feb 2024 | Announcement | ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |